Article Processing Charges (APC)
The MedSciens Journal of Immunology (MSJI) is an open-access journal providing a dedicated platform for researchers and clinicians in immunology and therapy. As a specialized outlet for studies on primary immunodeficiencies, inborn errors of immunity, and associated diseases, MSJI delves into genetic factors, diverse phenotypes-including infections, malignancies, allergic reactions, auto-inflammatory conditions, and autoimmune issues-and the immune system's roles in tissue development, maintenance, repair, and responses to environmental stressors. By welcoming technically valid and scientifically justified submissions, including meaningful reports on negative results, the journal fosters a supportive environment for bridging immunology and therapeutic applications across various organisms. Our commitment to open access ensures unrestricted dissemination of knowledge, enhancing patient safety and best practices in immunology without barriers. All manuscripts undergo rigorous peer review by expert editorial board members, upholding integrity, quality, and relevance in immunological research.
Our Article Processing Charge (APC) of $1,100 is designed to sustain MSJI's focus on immunological excellence and innovation. This fee covers essential services such as expert peer review, professional editing and formatting, and seamless online dissemination through advanced digital platforms. It also includes investments in hardware, software, and long-term digital preservation in secure repositories, guaranteeing your research's accessibility for future immunological studies and clinical applications. Authors publishing in MSJI benefit from enhanced visibility in immunology databases, increased citation potential, and opportunities to influence therapeutic developments, disease management, and patient care protocols. We welcome submissions of editorials, original research, review articles, case reports, and perspectives, all reviewed to elevate scholarly standards and community progress in immunology and therapy.
To promote equitable contributions to immunological research, MSJI adheres to a comprehensive Waiver Policy. We recognize that funding availability can vary significantly, so we offer substantial waivers for deserving authors whose institutions lack financial support or for those from low-income economies. These waivers, whether partial or full, are evaluated on a case-by-case basis to promote inclusivity and encourage global contributions. Requests must be submitted to the journal before manuscript submission to ensure fair consideration. This policy underscores our commitment to accessibility, allowing talented researchers to publish without financial hurdles.
Additionally, our Withdrawal Policy ensures transparency and fairness in the publication process. Authors may withdraw their article before the plagiarism check at no cost. However, if withdrawal occurs after the plagiarism check (within 24 hours) and formatting, a fee of $189 applies. For manuscripts that have undergone peer review and are prepared for publication, the fee increases to $459. Once an article is published, the withdrawal fee is $549. These charges reflect the resources invested in the process and align with our open-access model, where fees are non-refundable upon payment to cover editorial, review, and dissemination costs.
Publishing with MSJI positions you at the forefront of immunology and therapy innovation, where your work can advance understanding of immune disorders, improve treatments, and enhance patient safety. With no submission fees and flexible payment options like credit cards or institutional transfers, the process is user-friendly. For inquiries or APC negotiations, contact accounts@medscienspublishinggroup.com. Advance immunological science-submit your work today and strengthen global health defenses!